Healthcare Triangle, Inc. | December 14, 2021
Healthcare Triangle, Inc. (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform company, announced today that it has acquired DevCool, Inc. (“DevCool”), ranked by Inc. 5000 as among the fastest growing private companies in USA in 2021.
DevCool provides EHR Implementation and Managed Services to 6 of the top 10 hospitals in the USA and specializes in providing services to cancer research hospitals and university medical centres. The combined entity will focus on accelerating healthcare providers to adopt cloud technologies in improving clinical, operational, and financial performance. This will open up significant opportunities for HCTI, a premier partner of AWS, Google Cloud, and Microsoft Azure, to upsell its SaaS Platforms like CloudEz, DataEz, and Readabl.AI to the existing client base of DevCool.
“With the acquisition of DevCool, Healthcare Triangle will implement technological advancements designed to improve hospitals' provisioning of patient care, reduce information technology costs, and enable faster EHR deployments for hospital clients as part of its strategy to consolidate its leadership position in the healthcare space. This will further allow clients to host their EHR on public clouds (Amazon Web Services, Google Cloud, and Microsoft Azure) with the HCTI’s CloudEz Platform and expertise.”
Suresh Venkatachari, Chairman and CEO of Healthcare Triangle, Inc
He added that, "With the acquisition of DevCool, we will add large health systems and Integrated Delivery Networks (IDN) to HCTI’s client portfolio, and we expect it to be accretive to EBITDA.”
“We see the acquisition of DevCool improving patient outcomes by implementing AI and Data driven platforms across medical centers and clinical facilities. Healthcare Triangle (HCTI) expects significant opportunities in cloud transformation services, further growth of data analytics and AI platforms based recurring revenues in the healthcare domain,” said Shibu Kizhakevilayil, Head of M&A and Board of Director of Healthcare Triangle Inc. “We look forward to working with Sandeep Deokule and the DevCool team in our continued journey to become a top 10 healthcare IT company in US,” said Mr. Kizhakevilayil.
"We are excited to be part of HCTI, and our goal is to continue helping hospitals innovate and at the same time keep EHR Managed Services cost lower,” said Sandeep Deokule, founder of DevCool. "DevCool along with HCTI will now be able to scale faster, deliver large scale EHR implementations, and host applications on the cloud.”
About Healthcare Triangle, Inc. (HCTI)
Healthcare Triangle, Inc., based in Pleasanton, Calif., reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations—including hospitals and health systems and health plans—as well as pharma and life sciences organizations, in their efforts to improve health outcomes. Healthcare Triangle enables the rapid adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.
DevCool, Inc., Fastest Growing Company in USA in 2021 (by Inc. 5000 Magazine) is a trusted technology and business solutions provider for America's top healthcare organizations by providing EHR IT Managed Services. DevCool helps to rethink Healthcare delivery models by combining cutting edge Healthcare IT solutions and EHR Managed Services.
InComm Payments | May 31, 2021
InComm Payments, a leading global payments technology company, announced it's partnered with Visa to launch a first-of-its-kind innovative healthcare benefits solution. The dual Network Benefit Card combines the closed-loop, UPC-restricted-spend OTC Network® and open-loop Visa network in a single card, enabling health plans to simplify their supplemental benefits and incentives offerings further.
This hybrid solution allows health plans to deliver benefits like dental, vision, hearing, and other programs across a wide variety of providers through the Visa network while continuing to offer curated catalogs and directed services – like over-the-counter (OTC) medications, supplemental benefits, and healthy foods – through merchants in the UPC-restricted-spend OTC Network. Both options will restrict spending to approved items or providers, ensuring plan-provided dollars are spent on members' health care needs. The wholly configurable nature of the answer allows plans to tailor their benefits and incentives programs to satisfy members' needs and own the member experience across brick-and-mortar retail, online and mail-order channels.
The program offers easy-to-navigate, consolidated benefits administration for health plans, eliminating the need to provide separate cards for various benefits and incentive programs. The ability to restrict benefits at the UPC level via OTC Network retail partners ensures additional incentive dollars are spent on qualifying products. The Visa network allows for spending at specific medical merchant categories, expanding the available provider network while also restricting approved care. This eliminates both the need to manage dental, vision, and other additional provider networks and complicated reimbursement processes by simply adding funds to the card and allowing the member to choose their provider.
"This is a game-changer in how healthcare benefits will be managed, giving health plans greater flexibility when it comes to allocating their benefits – ensuring members get them when and where it matters most," said Brian Parlotto, Executive vice president at InComm Payments. "We're excited to continue innovating in this space by simplifying the healthcare benefits process for members and plans."
"This is a great opportunity for health plans to increase member satisfaction by consolidating many functionalities in one benefit card," said Darren Parslow, Global Head, Processing and Partner Solutions at Visa. "The reach of the Visa network benefits both healthcare providers, who can attract new customers, and also health plan members, who can direct their benefits to the services they need."
InComm Healthcare currently serves millions of health plan members through its OTC Network Product Suite, which features supplemental benefit and wellness incentive cards that effectively attract, engage and retain health plan members while driving them to adopt healthier behaviors. With various product catalogs to choose from, plans can customize their benefits and rewards to their specific consumer base. Its multi-wallet program allows to deliver and manage multiple member benefits through a single card.
About InComm Payments
InComm Payments is a global leader in innovative payments technology. Leveraging dynamic technology and proven expertise, InComm Payments delivers enhanced end-to-end payment platforms and emerging financial technology solutions that help businesses grow across various industries, including retail, healthcare, tolling & transit, incentives, mobile payments, and financial services. By enabling omnichannel connections to an ever-expanding consumer base in an increasingly digital ecosystem, InComm Payments creates seamless and valuable commerce experiences across the globe. With more than 25 years of experience, over 500,000 points of distribution, 386 global patents, and a presence in more than 30 countries, InComm Payments leads the payments industry from its headquarters in Atlanta, Ga.
ETAO International Group | October 27, 2021
ETAO International Group ("ETAO") announces the acquisition of Dnurse, a provider of digital diabetic management services. This innovative technology can improve outcomes for patients with diabetes and has the potential to be used in the treatment of all chronic diseases. The incidence of diabetes is increasing globally and has become a critical public health concern. In particular, diabetes has a leading public health challenge in China. According to the WHO, approximately 345 million individuals are afflicted with some form of diabetes in China. If left untreated, diabetes can lead to devastating complications, such as heart disease, nerve damage, blindness, kidney failure and amputations.
Dnurse provides patients with a technologically innovative self-management solution that increases compliance with critical treatment requirements, thereby improving patient outcomes. This new diabetic care combines people-first services with digital technology to remove limitations of traditional diabetic care.
Dr. Lee Winter, President of Etao International Group, has over 35 years of experience in healthcare as a former attending anesthesiologist and director of business development as Maimonides Medical Center Department of Anesthesiology and as former chair of the New York Presbyterian Lower Manhattan Hospital.
"Dnurse's low-cost, high-efficiency and easy-to-use diabetes self-management solution is extremely scalable and has the potential to significantly improve diabetic care. The digital interface increases client compliance, thereby reducing the risk of diabetic complications and improving patient outcomes. This cost-effective manner of efficiently preventing chronic disease complications has the potential to help patients manage any kind of chronic disease."
Dr. Lee Winter, President of Etao International Group
Leading this innovation solution is the co-founder and CEO of Dnurse, Jason Li. He has over 14 years of experience in the technology sector, including his role as the China CEO of Infosonics, VP of Techfaith Group and development engineer for Motorola. He said, "Dnurse plans to use the world's latest health care solutions and resources to serve the diabetic patients' needs. We are working with ETAO International Group to create a synergy that will secure a more sizable market presence, create a brand consistent with best diabetic care and reshape the established diabetic management landscape."
Founded in 2013, Dnurse was heavily invested by Sinocare and Innovation Works (now Sinovation Ventures), and SAIF. As the largest glucose meter manufacturer in Asia, Sinocare provides Dnurse with advanced biochemical technology, registration, delivery, and customization capacity.
Based on its Smart Glucose Meter, Dnurse has successfully built an innovation business model: Device + App + Service. Dnurse is also relying on its powerful AI decision system, IDSS (Intelligent Decision Support System), to make its diabetic management packages optimized for patients, burden-free, consistent, and humanistic. With the Dnurse App, a smart blood sugar testing meter can transfer information to a patient's smart phone. The mobile application allows for testing, data storage, personal feedback, sharing, customized reminders, and coaching, available to the patient every day and everywhere. Dnurse's smart diabetes care products are already serving 1.6 million diabetic patients.
About Etao International Group
Etao International Group ("Etao"), a Cayman Islands company, aims to be the world's leading digital healthcare group providing telemedicine, hospital care, primary care, pharmacy and health insurance covering all life stages of patients. "Etao" brand means "Best Medical Way" with transformative medical care and unparalleled service. Etao provides best-in-class internet medical services, such as artificial intelligence and big data technologies, to improve health care delivery and quality in specialized clinics and hospital settings. Etao's platform is seamlessly integrated because of its ability to combine technology and health sciences. Etao's US subsidiary was established in December 2017 in Delaware USA, and its wholly owned subsidiary Fangzhou Yidao (Beijing) Health Technology Co., Ltd. ("Etao China"), was established in Beijing in July 2019.
Dnurse was founded in Beijing China in July 2013 and is the first Chinese innovation mobile medical company whose mission is to reform traditional diabetes management. Dnurse offers personalized and professional diabetes management solutions. Its IoT & AI technology effectively improves diabetics compliance and attracted 1.6 million diabetes users. Dnurse is the largest platform of diabetic patients in China, and the No.1 smart glucometer manufacturer in China and India. Its closed loop service consists of diabetes hospitals, providing patients online referral, online prescription, and drug purchase services. Low- cost and efficiency helps diabetics patients' self-management and improved patient compliance.